Related Experiment Videos
NM23 expression as prognostic factor in colorectal carcinoma
A Forte1, A D'Urso, L S Gallinaro
1Department of Surgical Sciences and Applied Medical Technologies, Fourth Surgical Clinic, La Sapienza University, Rome.
Il Giornale Di Chirurgia
|July 12, 2002
Summary
NM23 gene expression is not an independent prognostic indicator for colorectal carcinoma. This study analyzed NM23 expression in 104 patients, finding no significant correlation with patient outcomes.
Area of Science:
- Oncology
- Molecular Biology
- Cancer Research
Background:
- Tumor stage is the primary prognostic indicator in colorectal carcinoma.
- The prognostic role of the NM23 gene in colorectal cancer remains controversial.
- Investigating NM23 gene expression is crucial for understanding colorectal cancer prognosis.
Purpose of the Study:
- To investigate the expression of the NM23 gene in colorectal carcinoma.
- To determine if NM23 expression can serve as an independent prognostic variable.
- To correlate NM23 expression levels with patient outcomes in colorectal cancer.
Main Methods:
- The study included 104 patients who underwent surgery for colorectal carcinoma.
- NM23 expression was quantified by assessing the percentage of tumor cells with immunoreactivity.
- A scoring system (0-3) was used to categorize NM23 expression levels.
Main Results:
- The distribution of NM23 expression scores was: 4 cases in group 0, 21 in group 1, 55 in group 2, and 24 in group 3.
- A significant portion of tumors showed varying levels of NM23 expression.
- Analysis did not reveal NM23 expression as a significant independent predictor of prognosis.
Conclusions:
- NM23 expression levels in colorectal carcinoma do not appear to be an independent prognostic variable.
- Further research may be needed to clarify the precise role of NM23 in colorectal cancer.
- Current findings suggest focusing on established prognostic factors like tumor stage.